U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


MORE ROBERT J (0001207792)
Mailing Address
680 S CACHE STREET, SUITE 100
BOX 10820
JACKSON WY 83001
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Tyra Biosciences, Inc. 0001863127 2021-09-14 director, 10 percent owner
Vir Biotechnology, Inc. 0001706431 2019-10-10 director
Allakos Inc. 0001564824 2018-07-18 10 percent owner
Sienna Biopharmaceuticals, Inc. 0001656328 2017-07-26 director
GLAUKOS Corp
Current Name:GLAUKOS CORP		 0001192448 2015-06-24 director
Orexigen Therapeutics, Inc. 0001382911 2007-04-25 10 percent owner
CADENCE PHARMACEUTICALS INC 0001333248 2006-10-24 10 percent owner
Volcano CORP 0001354217 2006-06-14 10 percent owner
Paratek Pharmaceuticals, Inc. 0001178711 2006-05-09 10 percent owner
Northstar Neuroscience, Inc. 0001351509 2006-05-04 10 percent owner
Vanda Pharmaceuticals Inc. 0001347178 2006-04-12 10 percent owner
IOMAI CORP
Current Name:INTERCELL USA, INC.		 0001125001 2006-01-25 10 percent owner
Somaxon Pharmaceuticals, Inc.
Current Name:Pernix Sleep, Inc.		 0001339455 2005-12-14 10 percent owner
NUVASIVE INC 0001142596 2004-05-12 10 percent owner
SANTARUS INC 0001172480 2004-03-31 10 percent owner


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-05-30   Vir Biotechnology, Inc. 4 A-Award --D 16000.0000 16000.0000 3 0001706431 Stock Option (Right to Buy)
A 2024-05-30   Vir Biotechnology, Inc. 4 A-Award --D 8000.0000 46683.0000 1 0001706431 Common Stock
A 2024-05-29   Tyra Biosciences, Inc. 4 A-Award --D 18600.0000 18600.0000 1 0001863127 Stock Option (Right to Buy)
A 2023-10-19   Vir Biotechnology, Inc. 4 J-Other --I 6405.0000 495890.0000 2 0001706431 Common Stock
D 2023-10-19   Vir Biotechnology, Inc. 4 J-Other --D 6405.0000 38683.0000 1 0001706431 Common Stock
A 2023-05-31   Tyra Biosciences, Inc. 4 A-Award --D 14500.0000 14500.0000 1 0001863127 Stock Option (Right to Buy)
A 2023-05-22   Vir Biotechnology, Inc. 4 A-Award --D 12054.0000 12054.0000 3 0001706431 Stock Option (Right to Buy)
A 2023-05-22   Vir Biotechnology, Inc. 4 A-Award --D 6027.0000 45088.0000 1 0001706431 Common Stock
A 2022-06-13   Tyra Biosciences, Inc. 4 A-Award --D 14500.0000 14500.0000 1 0001863127 Stock Option (Right to Buy)
A 2022-06-09   Vir Biotechnology, Inc. 4 J-Other --I 3374.0000 489485.0000 2 0001706431 Common Stock
D 2022-06-09   Vir Biotechnology, Inc. 4 J-Other --D 3374.0000 39061.0000 1 0001706431 Common Stock
A 2022-05-23   Vir Biotechnology, Inc. 4 A-Award --D 12810.0000 12810.0000 3 0001706431 Stock Option (Right to Buy)
A 2022-05-23   Vir Biotechnology, Inc. 4 A-Award --D 6405.0000 42435.0000 1 0001706431 Common Stock
D 2021-09-17   Tyra Biosciences, Inc. 4 C-Conversion --I 255160.0000 0.0000 4 0001863127 Series B Preferred Stock
D 2021-09-17   Tyra Biosciences, Inc. 4 C-Conversion --I 1212122.0000 0.0000 3 0001863127 Series A Preferred Stock
A 2021-09-17   Tyra Biosciences, Inc. 4 P-Purchase --I 156250.0000 4080296.0000 2 0001863127 Common Stock
A 2021-09-17   Tyra Biosciences, Inc. 4 C-Conversion --I 3811117.0000 3924046.0000 1 0001863127 Common Stock
D 2021-07-29   Vir Biotechnology, Inc. 4 S-Sale --D 2348.0000 36030.0000 3 0001706431 Common Stock
D 2021-07-29   Vir Biotechnology, Inc. 4 S-Sale --D 9322.0000 38378.0000 2 0001706431 Common Stock
D 2021-07-15   Vir Biotechnology, Inc. 4 S-Sale --D 11670.0000 46029.0000 1 0001706431 Common Stock
A 2021-07-01   Vir Biotechnology, Inc. 4 A-Award --D 1671.0000 47700.0000 1 0001706431 Common Stock
D 2021-07-01   Vir Biotechnology, Inc. 4 S-Sale --D 890.0000 57699.0000 3 0001706431 Common Stock
D 2021-07-01   Vir Biotechnology, Inc. 4 S-Sale --D 5986.0000 58589.0000 2 0001706431 Common Stock
D 2021-07-01   Vir Biotechnology, Inc. 4 S-Sale --D 4794.0000 64575.0000 1 0001706431 Common Stock
D 2021-06-17   Vir Biotechnology, Inc. 4 S-Sale --D 11670.0000 69369.0000 1 0001706431 Common Stock
D 2021-06-03   Vir Biotechnology, Inc. 4 S-Sale --D 11670.0000 81039.0000 1 0001706431 Common Stock
A 2021-05-21   Vir Biotechnology, Inc. 4 A-Award --D 6748.0000 6748.0000 3 0001706431 Stock Option (Right to Buy)
D 2021-05-21   Vir Biotechnology, Inc. 4 A-Award --D 3374.0000 92709.0000 1 0001706431 Common Stock
D 2021-05-20   Vir Biotechnology, Inc. 4 S-Sale --D 9095.0000 89335.0000 2 0001706431 Common Stock
D 2021-05-20   Vir Biotechnology, Inc. 4 S-Sale --D 2575.0000 98430.0000 1 0001706431 Common Stock
D 2021-03-05   Allakos Inc. 4 S-Sale --D 605.0000 0.0000 19 0001564824 Common Stock
D 2021-03-05   Allakos Inc. 4 S-Sale --D 1000.0000 605.0000 18 0001564824 Common Stock
D 2021-03-05   Allakos Inc. 4 S-Sale --D 1600.0000 1605.0000 17 0001564824 Common Stock
D 2021-03-05   Allakos Inc. 4 S-Sale --D 1300.0000 3205.0000 16 0001564824 Common Stock
D 2021-03-05   Allakos Inc. 4 S-Sale --D 1700.0000 4505.0000 15 0001564824 Common Stock
D 2021-03-05   Allakos Inc. 4 S-Sale --D 3871.0000 6205.0000 14 0001564824 Common Stock
D 2021-03-05   Allakos Inc. 4 S-Sale --D 2600.0000 10076.0000 13 0001564824 Common Stock
D 2021-03-04   Allakos Inc. 4 S-Sale --D 100.0000 12676.0000 12 0001564824 Common Stock
D 2021-03-04   Allakos Inc. 4 S-Sale --D 5914.0000 12776.0000 11 0001564824 Common Stock
D 2021-03-04   Allakos Inc. 4 S-Sale --D 3280.0000 18690.0000 10 0001564824 Common Stock
D 2021-03-04   Allakos Inc. 4 S-Sale --D 1810.0000 21970.0000 9 0001564824 Common Stock
D 2021-03-04   Allakos Inc. 4 S-Sale --D 2796.0000 23780.0000 8 0001564824 Common Stock
D 2021-03-04   Allakos Inc. 4 S-Sale --D 1100.0000 26576.0000 7 0001564824 Common Stock
D 2021-03-03   Allakos Inc. 4 S-Sale --D 1900.0000 30254.0000 3 0001564824 Common Stock
D 2021-03-03   Allakos Inc. 4 S-Sale --D 400.0000 32154.0000 2 0001564824 Common Stock
D 2021-03-03   Allakos Inc. 4 S-Sale --D 300.0000 29954.0000 4 0001564824 Common Stock
D 2021-03-03   Allakos Inc. 4 S-Sale --D 400.0000 29554.0000 5 0001564824 Common Stock
D 2021-03-03   Allakos Inc. 4 S-Sale --D 1878.0000 27676.0000 6 0001564824 Common Stock
A 2020-05-21   Vir Biotechnology, Inc. 4/A A-Award --D 24355.0000 24355.0000 1 0001706431 Stock Option (Right to Buy)
A 2020-05-21   Vir Biotechnology, Inc. 4 A-Award --D 28888.0000 28888.0000 1 0001706431 Stock Option (Right to Buy)
D 2020-05-18   Allakos Inc. 4 S-Sale --D 600.0000 0.0000 3 0001564824 Common Stock
D 2020-05-18   Allakos Inc. 4 S-Sale --D 4506.0000 600.0000 2 0001564824 Common Stock
D 2020-05-18   Allakos Inc. 4 S-Sale --D 6432.0000 5106.0000 1 0001564824 Common Stock
D 2020-05-01   Vir Biotechnology, Inc. 4 S-Sale --D 2700.0000 71534.0000 2 0001706431 Common Stock
D 2020-05-01   Vir Biotechnology, Inc. 4 S-Sale --D 15758.0000 74234.0000 1 0001706431 Common Stock
D 2019-10-16   Vir Biotechnology, Inc. 4 C-Conversion --I 277777.0000 0.0000 5 0001706431 Series B Convertible Preferred Stock
D 2019-10-16   Vir Biotechnology, Inc. 4 C-Conversion --D 60822.0000 0.0000 4 0001706431 Series A-2 Convertible Preferred Stock
D 2019-10-16   Vir Biotechnology, Inc. 4 C-Conversion --I 1666666.0000 0.0000 3 0001706431 Series A-1 Convertible Preferred Stock
A 2019-10-16   Vir Biotechnology, Inc. 4 C-Conversion --D 60822.0000 60822.0000 2 0001706431 Common Stock
A 2019-10-16   Vir Biotechnology, Inc. 4 C-Conversion --I 1944443.0000 1944443.0000 1 0001706431 Common Stock
A 2019-05-30   Sienna Biopharmaceuticals, Inc. 4 A-Award --D 25000.0000 25000.0000 1 0001656328 Stock Options (Right to buy)
A 2019-02-22   Sienna Biopharmaceuticals, Inc. 4 P-Purchase --D 100000.0000 255942.0000 1 0001656328 Common Stock
A 2018-06-01   Sienna Biopharmaceuticals, Inc. 4 A-Award --D 10000.0000 10000.0000 1 0001656328 Stock Options (Right to buy)
D 2018-03-29   Sienna Biopharmaceuticals, Inc. 4 S-Sale --D 14429.0000 178820.0000 2 0001656328 Common Stock
D 2018-03-28   Sienna Biopharmaceuticals, Inc. 4 S-Sale --D 10000.0000 193249.0000 1 0001656328 Common Stock
A 2017-08-01   Sienna Biopharmaceuticals, Inc. 4 C-Conversion --D 136286.0000 170357.0000 1 0001656328 Common Stock
A 2017-08-01   Sienna Biopharmaceuticals, Inc. 4 C-Conversion --D 32892.0000 203249.0000 2 0001656328 Common Stock
D 2017-08-01   Sienna Biopharmaceuticals, Inc. 4 C-Conversion --D 32892.0000 0.0000 4 0001656328 Series A-3 Preferred Stock
D 2017-08-01   Sienna Biopharmaceuticals, Inc. 4 C-Conversion --D 136286.0000 0.0000 3 0001656328 Series A-2 Preferred Stock
A 2015-06-24   GLAUKOS Corp 4 P-Purchase --D 5000.0000 5000.0000 1 0001192448 Common Stock
D 2008-07-16   Volcano CORP 4 S-Sale --I 15655.0000 62513.0000 2 0001354217 Common Stock
D 2008-07-16   Volcano CORP 4 J-Other --I 662711.0000 2646328.0000 1 0001354217 Common Stock
A 2008-04-24   Volcano CORP 4 J-Other --I 1480.0000 56718.0000 2 0001354217 Common Stock
A 2008-04-24   Volcano CORP 4 J-Other --D 16838.0000 16838.0000 1 0001354217 Common Stock
D 2008-04-08   Volcano CORP 4 S-Sale --I 13613.0000 78168.0000 2 0001354217 Common Stock
D 2008-04-08   Volcano CORP 4 J-Other --I 576270.0000 3309039.0000 1 0001354217 Common Stock
A 2008-02-20   CADENCE PHARMACEUTICALS INC 4 A-Award --I 29785.0000 90369.0000 2 0001333248 Common Stock
A 2008-02-20   CADENCE PHARMACEUTICALS INC 4 A-Award --I 2779203.0000 8432241.0000 1 0001333248 Common Stock
D 2007-11-27   Orexigen Therapeutics, Inc. 4 J-Other --I 900000.0000 3543832.0000 1 0001382911 Common Stock
A 2007-11-27   Orexigen Therapeutics, Inc. 4 J-Other --I 1963.0000 1963.0000 2 0001382911 Common Stock

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016